| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/01/2014 | US8686030 Anti-cancer extract and compounds |
| 04/01/2014 | US8686029 Synergistic antioxidant compositions |
| 04/01/2014 | US8686028 Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders |
| 04/01/2014 | US8686027 Method for treating bronchial diseases |
| 04/01/2014 | US8686026 Solid compositions |
| 04/01/2014 | US8686025 Therapeutic lactams |
| 04/01/2014 | US8686024 Indoline derivatives |
| 04/01/2014 | US8686023 Salts of sunitinib |
| 04/01/2014 | US8686022 7-(piperazine-1-ymethyl)-1H-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 MAP kinase inhibitors for the treatment of respiratory diseases |
| 04/01/2014 | US8686021 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin E2 (PGE2) |
| 04/01/2014 | US8686020 Spirocyclic compounds |
| 04/01/2014 | US8686019 Use of amisulpride as an anti-emetic |
| 04/01/2014 | US8686018 Pharmaceutical composition |
| 04/01/2014 | US8686017 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom |
| 04/01/2014 | US8686016 Schweinfurthins and uses thereof |
| 04/01/2014 | US8686015 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents |
| 04/01/2014 | US8686013 Cosmetic use of substituted amino heterocylic carbamoyl analogs and related compounds |
| 04/01/2014 | US8686012 Stem cell differentiating agents and uses therefor |
| 04/01/2014 | US8686011 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 04/01/2014 | US8686010 Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors |
| 04/01/2014 | US8686009 Prodrugs of NH-acidic compounds |
| 04/01/2014 | US8686008 Highly selective sigma receptor ligands |
| 04/01/2014 | US8686007 Certain heterocycles, compositions thereof, and methods for their use |
| 04/01/2014 | US8686006 Pharmaceutical composition for improving intestinal absorption |
| 04/01/2014 | US8686003 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification |
| 04/01/2014 | US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors |
| 04/01/2014 | US8686001 Medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 04/01/2014 | US8686000 Herbicidally active ketosultams and diketopyridines |
| 04/01/2014 | US8685999 Beta carboline sulphonylurea derivatives as EP4 receptor antagonists |
| 04/01/2014 | US8685998 Tacrolimus for improved treatment of transplant patients |
| 04/01/2014 | US8685997 Camptothecin derivatives and their use |
| 04/01/2014 | US8685996 Methods for making 3-O-protected morphinones and 3-O-protected morphinone dienol carboxylates |
| 04/01/2014 | US8685995 Treatment with opioid antagonists and mTOR inhibitors |
| 04/01/2014 | US8685994 Analgesic combination of oxycodone and celecoxib |
| 04/01/2014 | US8685993 Bi-heteroaryl compounds as Vps34 inhibitors |
| 04/01/2014 | US8685992 Histone deacetylase inhibitors based simultaneously on trisubstituted 1H-pyrroles and aromatic and heteroaromatic spacers |
| 04/01/2014 | US8685989 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 04/01/2014 | US8685988 EGFR modulators and uses thereof |
| 04/01/2014 | US8685987 Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators |
| 04/01/2014 | US8685986 Medical composition for treatment or prophylaxis of glaucoma |
| 04/01/2014 | US8685985 Selective insecticides based on anthranilic acid diamides and safeners |
| 04/01/2014 | US8685984 Methods for treating HCV |
| 04/01/2014 | US8685983 Method of treating cancer with substituted amide derivatives |
| 04/01/2014 | US8685982 Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors |
| 04/01/2014 | US8685981 Cyclic compound having hetero atom |
| 04/01/2014 | US8685980 Pyrrolopyrimidine compounds and their uses |
| 04/01/2014 | US8685979 Oligomer-diarylpiperazine conjugates |
| 04/01/2014 | US8685978 Spectinamides as anti-tuberculosis agents |
| 04/01/2014 | US8685977 Chemical compounds |
| 04/01/2014 | US8685976 Cell adhesion promoting agent and method of promoting cell adhesion |
| 04/01/2014 | US8685975 PDE10 inhibitors and related compositions and methods |
| 04/01/2014 | US8685974 Thienylpyri(mi)dinylazole |
| 04/01/2014 | US8685973 Pyrimidine cyclohexyl glucocorticoid receptor modulators |
| 04/01/2014 | US8685972 Pyrimidine derivatives for treatment of alzheimer's disease |
| 04/01/2014 | US8685971 Quinolinyloxyphenylsulfonamides |
| 04/01/2014 | US8685970 Quinolines and related analogs as sirtuin modulators |
| 04/01/2014 | US8685968 Pharmaceutical compounds |
| 04/01/2014 | US8685967 Substituted triazolopyridines and analogs thereof |
| 04/01/2014 | US8685966 GRP94 inhibitors |
| 04/01/2014 | US8685965 CGRP receptor antagonists |
| 04/01/2014 | US8685963 Compounds that inhibit NFκB and BACE1 activity |
| 04/01/2014 | US8685962 Compositions, articles and methods comprising TSPO ligands for preventing or reducing tobacco-associated damage |
| 04/01/2014 | US8685961 Diazepan orexin receptor antagonists |
| 04/01/2014 | US8685960 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CYP11B2 |
| 04/01/2014 | US8685957 Tazobactam arginine compositions |
| 04/01/2014 | US8685956 Compositions and methods for reducing the risk of agent-induced liver toxicity |
| 04/01/2014 | US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 04/01/2014 | US8685954 Methods and compositions for treating cancer using proteasome inhibitors |
| 04/01/2014 | US8685953 Linear and cyclic guanidine derivatives, method of preparation and uses thereof |
| 04/01/2014 | US8685952 Method for the treatment of diabetes |
| 04/01/2014 | US8685951 Compositions and methods for cytoprotection |
| 04/01/2014 | US8685950 Use of aromatase inhibitors for treatment of ectopic pregnancy |
| 04/01/2014 | US8685949 Use of 25-hydroxy vitamin D3 to improve vitality of animals |
| 04/01/2014 | US8685948 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| 04/01/2014 | US8685947 Compositions and methods for loop diuretics with consistent bioavailability |
| 04/01/2014 | US8685945 Polymeric artificial tear system |
| 04/01/2014 | US8685944 Viscoelastic gel for dermatological use |
| 04/01/2014 | US8685943 Methods for reducing diarrhea in a companion animal |
| 04/01/2014 | US8685942 Sophorolipid analog compositions |
| 04/01/2014 | US8685941 Drug composition cytotoxic for pancreatic cancer cells |
| 04/01/2014 | US8685940 Impaired wound healing compositions and treatments |
| 04/01/2014 | US8685939 Vaccine targeting cellular death receptor DR5 |
| 04/01/2014 | US8685937 Nucleic acid aptamers |
| 04/01/2014 | US8685936 Sphingosine kinase inhibitor prodrugs |
| 04/01/2014 | US8685935 Use of flavonoids to increase the bioavailability of hesperetin |
| 04/01/2014 | US8685934 Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof |
| 04/01/2014 | US8685929 Detecting CYP24 expression level as a marker for predisposition to cancer |
| 04/01/2014 | US8685887 Surfactant compositions |
| 04/01/2014 | US8685664 Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease |
| 04/01/2014 | US8685661 Reagent and kit for classifying and counting leukocytes, the preparation thereof, and process for classifying and counting leukocytes |
| 04/01/2014 | US8685460 Treatment using dantrolene |
| 04/01/2014 | US8685458 Pharmaceutical compositions of dextran polymer derivatives |
| 04/01/2014 | US8685454 Lubricating composition |
| 04/01/2014 | US8685453 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 04/01/2014 | US8685452 Pharmaceutical composition |
| 04/01/2014 | US8685451 Triple combination release multi-layered tablet |
| 04/01/2014 | US8685445 Enteric composition for the manufacture of soft capsule wall |
| 04/01/2014 | US8685438 Compositions, kits, and methods utilizing an added boron source |
| 04/01/2014 | US8685436 Use of hydroxyflavanones for masking bitter taste |
| 04/01/2014 | US8685435 Extended release biodegradable ocular implants |